| 000 | 01355 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512044058.0 | ||
| 264 | 0 | _c19880506 | |
| 008 | 198805s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/80.4.276 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLong, H J | |
| 245 | 0 | 0 |
_aPhase II evaluation of carboplatin in advanced endometrial carcinoma. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cApr 1988 |
||
| 300 |
_a276-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBlood Cell Count |
| 650 | 0 | 4 | _aCarboplatin |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
| 650 | 0 | 4 |
_aUterine Neoplasms _xdrug therapy |
| 700 | 1 | _aPfeifle, D M | |
| 700 | 1 | _aWieand, H S | |
| 700 | 1 | _aKrook, J E | |
| 700 | 1 | _aEdmonson, J H | |
| 700 | 1 | _aBuckner, J C | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 80 _gno. 4 _gp. 276-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/80.4.276 _zAvailable from publisher's website |
| 999 |
_c3286571 _d3286571 |
||